Early influenza vaccine effectiveness estimates using routinely collected data, Alberta, Canada, 2023/24 season.
Euro Surveill
; 29(2)2024 Jan.
Article
em En
| MEDLINE
| ID: mdl-38214082
ABSTRACT
Timely and precise influenza vaccine effectiveness (VE) estimates are needed to guide public health messaging and impact vaccine uptake immediately. Using routinely collected laboratory, vaccination and health administrative data from Alberta, Canada, we estimated influenza VE against infection for the 2023/24 season on a near real-time basis, to late December, at 61% (95%â¯CI 58-64) against influenza A(H1N1), 49% (95%â¯CI 28-63) against influenza A(H3N2) and 75% (95%â¯CI 58-85) against influenza B.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Contexto em Saúde:
1_ASSA2030
/
2_ODS3
Base de dados:
MEDLINE
Assunto principal:
Vacinas contra Influenza
/
Influenza Humana
/
Vírus da Influenza A Subtipo H1N1
Tipo de estudo:
Observational_studies
/
Risk_factors_studies
Limite:
Humans
País/Região como assunto:
America do norte
Idioma:
En
Revista:
Euro Surveill
Ano de publicação:
2024
Tipo de documento:
Article